Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
New appointments follow PepGen’s recent $112.5 million crossover financing to advance therapies for neuromuscular diseases PepGen is rapidly advancing lead programs in Duchenne muscular dystrophy...
-
BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) -- PepGen, Inc., a company developing next-generation oligonucleotide therapies for neuromuscular and neurologic diseases, today announced the closing of an...
-
- Niels Svenstrup, Ph.D., will serve as Senior Vice President of Chemistry, Manufacturing & Controls - David Pelissier, CPA, will serve as Vice President of Finance - New leaders will support...